Brewin Dolphin LTD Ampio Pharmaceuticals, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Nov 09, 2023
SELL
$0.39 - $0.7 $4,418 - $7,930
-11,330 Closed
0 $0
Q2 2018

Nov 09, 2023
BUY
$1.66 - $3.82 $18,807 - $43,280
11,330 New
11,330 $24.9 Million

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0
View Full List

About Ampio Pharmaceuticals, Inc.

AMPE Quotes by TradingView
  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email